HD-PDT (n = 49) | SLL (n = 46) | P-Value | |
---|---|---|---|
Total observation time (weeks, median(IQR)) | 17.3 (9.9–24.2) | 17.7 (9.0-25.5) | 0.908* |
Patients with second treatment (n,%) | 22 (44.9) | 20 (43.5) | 0.889† |
Change in BCVA (logMAR, median (IQR)) | 0.10 (0.0-0.2) | 0.10 (0.0-0.2) | 0.344* |
Completely dry (n,%) | 30 (61.2) | 28 (60.9) | 0.972† |